Macquarie Group
QTTB icon

Macquarie Group’s Q32 Bio QTTB Stock Holding History

Macquarie Group’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-539
Closed -$29 – 2638
2022
Q1 		$29 Hold
539
– – ﹤0.01% 2307
2021
Q4 		$35K Sell
539
-243
-31% -$23.6K ﹤0.01% 2268
2021
Q3 		$111K Buy
782
+448
+134% +$57.1K ﹤0.01% 1949
2021
Q2 		$44K Buy
334
+294
+735% +$36.7K ﹤0.01% 2185
2021
Q1 		$7K Sell
40
-12
-23% -$2.53K ﹤0.01% 2432
2020
Q4 		$11K Hold
52
– – ﹤0.01% 2300
2020
Q3 		$10K Hold
52
– – ﹤0.01% 2284
2020
Q2 		$14K Buy
+52
New +$13.9K ﹤0.01% 2247

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group's QTTB Position: Q2 2022 in Review

Macquarie Group sold out of Q32 Bio (QTTB) in Q2 2022, closing a stake of 539 shares — an estimated $29 sold.

Macquarie Group first reported a position in QTTB in Q2 2020 and held it in 8 quarters. The position peaked at $111K in Q3 2021. 87 funds tracked by Wall St. Rank hold QTTB as of Q2 2022.

  • Macquarie Group reported no remaining Q32 Bio position as of Q2 2022 after selling out during the quarter.
  • Macquarie Group sold 539 Q32 Bio shares in Q2 2022, an estimated $29.
  • Macquarie Group first reported a position in Q32 Bio in Q2 2020 and held it in 8 quarters.
  • Macquarie Group's Q32 Bio position peaked at $111K in Q3 2021.
  • 87 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2022.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.